Core Insights - Johnson & Johnson Medical Technology launched the ETHICON 4000, the first 3D stapler for laparoscopic surgery in Asia, aimed at enhancing patient outcomes by improving tissue integrity during surgical procedures [1] - The CEREGLIDE 71 distal access catheter made its Asian debut, designed for neurovascular systems, which can reach critical areas in the brain, thus providing timely intervention for stroke patients [2] - The strong and flexible blood flow-directed mesh stent, developed in collaboration with a domestic medical innovation company, was also introduced, showcasing advancements in neurointerventional devices [2] Group 1 - The ETHICON 4000 laparoscopic stapler represents a significant technological advancement, transitioning from 2D to 3D stapling, which enhances the integrity of tissue connections and reduces the risk of complications such as blood leakage [1] - The innovative pre-set chip technology in the ETHICON 4000 allows for dynamic adjustment during the stapling process, potentially decreasing postoperative complications and improving patient recovery [1] Group 2 - The CEREGLIDE 71 distal access catheter is capable of reaching the M1-M2 segments of the brain, facilitating rapid access for stroke treatment, which is critical for patient outcomes [2] - The introduction of a complete thrombectomy product line, including the EMBOTRAP III and EMBOVAC devices, highlights Johnson & Johnson's commitment to advancing neurointerventional solutions [2] - The collaboration with a domestic company to develop the blood flow-directed stent emphasizes the trend of partnerships in the medical technology sector to enhance product offerings and address specific clinical needs [2]